MedStar Research Institute — Washington D.C., District of Columbia

MedStar Research Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20003.

Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

MedStar Research Institute has participated in 9 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2, Diabetes Type 2, Soft Tissue Sarcoma.

Sponsors: VeraLight, Inc., Novo Nordisk A/S, Alaunos Therapeutics.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Research Institute?

MedStar Research Institute has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Research Institute conducted?

MedStar Research Institute has 9 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Diabetes Type 2, Soft Tissue Sarcoma.

Is MedStar Research Institute accredited by Crixeo Clinical Trials?

MedStar Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.